Информация предназначена только для профессионалов в области здравоохранения.
Вы можете зайти как пользователь социальных сетей
ФГБУ Федеральный центр сердца, крови и эндокринологии им. В.А.Алмазова Минздрава РФ, Санкт-Петербург
Список исп. литературыСкрыть список 1. Афанасьев В.В. Солкосерил. Итоги и перспективы. Сб. научно-практических статей. Под ред. Ю.В.Лукьянова. СПб, 1997; с. 4–6. 2. Новик А.А., Матвеева С.А., Ионова Т.И. и др. Оценка качества жизни больного в медицине. Клин. мед. 2000; 2: 10–4. 3. Погосова Г.В. Антидепрессанты в клинической практике. Лечащий врач. 2002; 7–8. 4. Российские рекомендации по диагностике и лечению стабильной стенокардии. М., 2008. 5. Хубутия М.Ш., Шевченко О.П. Гомоцистеин при коронарной болезни сердца и сердечного трансплантата. М., 2004; с. 271. 6. Abela RZ, Hankin BL. Cognitive vulnerability to depression in children and adolescents: a developmental psychopathology perspective, in Handbook of Depression in Children and Adolescents. Ed.: R.Abela, B.Hankin. NY, Guilford 2008; p. 35–78. 7. Abercrombie HC, Schaefer SM, Larson CL et al. Metabolic rate in the right amygdala predicts negative affect in depressed patients. Neuroreport 1998; 9 (14): 3301–7. 8. Ades PA, Waldmann ML, McCann WJ, Weaver SO. Predictors of cardiac rehabilitation participation in older coronary patients. Arch Intern Med 1992; 152 (5): 1033–5. 9. Albert MA, Glynn RJ, Buring J, Ridker PM. Impact of traditional and novel risk factors on the relationship between socioeconomic status and incident cardiovascular events. Circulation 2006; 114 (24): 2619–26. 10. Albus C. Psychological and social factors in coronary heart disease. Ann Med 2010; 42 (7): 487–94. 11. Alexopoulos GS, Meyers BS, Young RC et al. Vascular depression hypothesis. Arch Gen Psychiat 1997; 54 (10): 915–22. 12. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. 4th ed. Text revision. Washington (DC): The Association 2000. 13. Anda RF, Croft JB, Felitti VJ et al. Adverse childhood experiences and smoking during health: 10 (1) adolescence and adulthood. J Am Med Association 1999; 282 (17): 1652–8. 14. Anderson IM, Tomenson BM. The efficacy of selective serotonin re-uptake inhibitors in depression: a meta-analysis of studies against tricyclic antidepressants. J Psychopharmacol 1994; 8 (4): 238–49. 15. Angelucci F, Mathe A, Aloe L. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res 2004; 146: 151–65. 16. Anisman H, Ravindran AV, Griffiths J, Merali Z. Endocrine and cytokine correlates of major depression and dysthymia with typical or atypical features. Mol Psychiat 1999; 4 (2): 182–8. 17. Arborelius L, Owens MJ, Plotsky PM, Nemeroff CB. The role of corticotropin-releasing factor in depression and anxiety disorders. J Endocrin 1999; 160 (1): 1–12. 18. Artigas F, Romero L, de Montigny C, Blier P. Acceleration of the effect of selected antidepressant drugs in major depression by 5HT1A-antagonists. Trends Neurosci 1996; 19 (9): 378–83. 19. Asnis GM, Halbreich U, Ryan ND et al. The relationship of the dexamethasone suppression test (1 mg and 2 mg) to basal plasma cortisol levels in endogenous depression. Psychoneuroendocrin 1987; 12 (4): 295–301. 20. Austin MP, Dougall N, Ross M et al. Single photon emission tomography with 99mTc-exametazime in major depression and the pattern of brain activity underlying the psychotic/neurotic continuum. J Affect Dis 1992; 26 (1): 31–43. 21. Bajwa WK, Asnis GM, Sanderson WC et al. High cholesterol levels in patients with panic disorder. Am J Psychiat 1992; 149 (3): 376–8. 22. Barger SD, Sydeman SJ. Does generalized anxiety disorder predict coronary heart disease risk factors independently of major depressive disorder? J Affect Dis 2005; 88 (1): 87–91. 23. Baxter LR, Schwartz JM, Phelps ME et al. Reduction of prefrontal cortex glucose metabolism common to three types of depression. Arch Gen Psychiat 1989; 46 (3): 243–50. 24. Beaufour CC, Le Bihan C, Hamon C, Thiébot MH. Extracellular serotonin is enchanced in the striatum, but not in the dorsal hippocampus or prefrontal cortex, in rats subjected to an operant conflict procedure. Behav Neurosci 2001; 115 (1): 125–37. 25. Beevers CG, Gibb BE, McGeary JE, Miller IW. Serotonin transporter genetic variation and biased attention for emotional word stimuli among psychiatric inpatients. J Abnorm Psychol 2007; 116 (1): 208–12. 26. Belzer K, Schneier FR. Comorbidity of anxiety and depressive disorders: issues in conceptualization, assessment, and treatment. J Psychiat Pract 2004; 10 (5): 296–306. 27. Bench CJ, Friston KJ, Brown RG et al. Regional cerebral blood flow in depression measured by positron emission tomography: the relationship with clinical dimensions. Psychol Med 1993; 23 (3): 579–90. 28. Berkman LF, Leo-Summers L, Horwitz RI. Emotional support and survival after myocardial infarction. A prospective, population-based study of the elderly. Ann Intern Med 1992; 117 (12): 1003–9. 29. Besedovsky HO, Ray A, Sorkin A. Immunoregulatory feedback between interleukin-1 and glucocorticoid hormones. Science 1986; 233: 652–4. 30. Biver F, Goldman S, Delvenne V et al. Frontal and parietal metabolic disturbances in unipolar depression. Biol Psychiat 1994; 36 (6): 381–8. 31. Bonne O, Krausz Y, Shapira B et al. Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. J Nucl Med 1996; 37 (7): 1075–80. 32. Booij L, Van der Does AJ. Cognitive and serotonergic vulnerability to depression: convergent findings. J Abnorm Psychol 2007; 116 (1): 86–94. 33. Bottiglieri T. Folate, vitamin B12, and neuropsychiatric disorders. Nutr Rev 1996; 54 (12): 382–90. 34. Alcohol and the blood. Chanarin I. Br J Haematol 1979; 42 (3): 333–6. 35. Brambilla F, Bellodi L, Brunetta M, Perna G. Plasma concentrations of interleukin-1b, interleukin-6 and tumor necrosis factor-a in anorexia and bulimia nervosa. Psychoneuroendocrin 1998; 23 (5): 439–47. 36. Breeze JL, Hesdorffer DC, Hong X et al. Clinical significance of brain white matter hyperintensities in young adults with psychiatric illness. Harv Rev Psychiat 2003; 11 (5): 269–83. 37. Breslau N, Kilbey M, Andreski P. Nicotine dependence, major depression, and anxiety in young adults. Arch Gen Psychiat 1991; 48 (12): 1069–74. 38. Breslau N, Peterson EL, Schultz LR et al. Major depression and stages of smoking. A longitudinal investigation. Arch Gen Psychiat 1998; 55 (2): 161–6. 39. Brewerton TD, Lydiard MR, Johnson MR. CSF Serotonin: diagnostic and seasonal differences. In: New research and abstracts of the 148th Annual Meeting of the American Psychiatric Association, May 20–25 1995. Miami Fla. Abstr. 358: 151. 40. Brody AL, Saxena S, Stoessel P et al. Regional brain metabolic changes in patients with major depression treated with either paroxetine or interpersonal therapy: preliminary findings. Arch Gen Psychiat 2001; 58 (7): 631–40. 41. Brown RA, Kahler CW, Niaura R et al. Cognitive-behavioral treatment for depression in smoking cessation. J Cons Clin Psychol 2001; 69 (3): 471–80. 42. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 2001; 63: 637–72. 43. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol 2001; 63: 637–72. 44. Brunner H, Cockcroft JR, Deanfield J et al. Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. Endothelial function and dysfunction. Part II: Association with cardiovascular risk factors and diseases. A statement by the Working Group on Endothelins and Endothelial Factors of the European Society of Hypertension. J Hypertens 2005; 23 (2): 233–46. 45. Buchsbaum MS, Wu J, Siegel BV et al. Effect of sertraline on regional metabolic rate in patients with affective disorder. Biol Psychiat 1997; 41 (1): 15–22. 46. Butler AC, Hokanson JE, Flynn HA. A comparison of self-esteem lability and low trait self-esteem as vulnerability factors for depression. J Pers Soc Psychol 1994; 66: 166–77. 47. Camacho TC, Roberts RE, Lazarus NB et al. Physical activity and depression: evidence from the Alameda County Study. Am J Epid 1991; 134 (2): 220–31. 48. Cangioli I, Baidi E, Mannaioni PF et al. Activation of histaminergic H3-receptors in the rat basolateral amygdale improves expression of fear memory and enchances acetylcholine release. Eur J Neurosci 2002; 16: 521–8. 49. Carney MW. Serum folate values in 423 psychiatric patients. Br Med J 1967; 4 (5578): 512–6. 50. Carney MW, Chary TK, Laundy M et al. Red cell folate concentrations in psychiatric patients. J Affect Dis 1990; 19 (3): 207–13.